Page 3 - Best Breast cancer doctors in Turkey: TOP 52 doctors

Associate Professor Dr. Emrah Eraslan has focused on breast cancer since 2013, bringing over 10 years of specialized expertise.

• Medical oncology training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital
• Specializes in breast, prostate, lung, and colorectal cancers
• Became associate professor in 2023 for contributions to oncology
• Served as chief physician at multiple hospitals
• Currently practices at Private Koru Ankara Hospital

Prof. Dr. Suleyman Alici has performed over 900 treatments in 34 years at Hisar Hospital Intercontinental.

• Specializes in metastatic breast cancer cases
• Personally reviews documents to tailor treatment plans
• Rated 4.4 out of 5 by patients

Specializes in breast cancer with international training at MD Anderson Cancer Center and Sunnybrook Odette Cancer Center.

• Board-certified in medical oncology with 15+ years of experience
• Trained at top cancer centers in the USA and Canada
• Works with a wide range of cancer types
• Currently practices at Valued Med Hub Hospitals

Prof. Tastekin specializes in breast cancer, with extensive academic training at Istanbul University Oncology Institute.

• Medical oncology subspecialist with 13+ years of experience
• Assistant professor roles at top Turkish universities
• Specializes in gastrointestinal, lung, and rare cancers alongside breast cancer

Prof. Dr. Cemil Bilir is a highly qualified medical oncologist with prestigious memberships in ASCO and ESMO.

• 15+ years of experience in medical oncology
• Trained at Bulent Ecevit University and Recep Tayyip Erdogan University
• Research experience at Northeastern University in the U.S.
• Professor at Sakarya University Faculty of Medicine
• Specialized in breast cancer treatment and research

Associate Professor Murat Ayhan specializes in breast cancer treatment at Liv Hospital Vadistanbul, with active involvement in international clinical trials.

• Participates in phase II and III trials for hormone receptor-positive breast cancer
• Published research on triple-negative breast cancer survival outcomes
• Expert in molecular oncology approaches
• Experienced in managing locally advanced and metastatic cases

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.